Blood lipid–hormone ratios predict future asthma attacks years in advance

	Asthma
	The latest asthma news from News Medical

	Blood lipid–hormone ratios predict future asthma attacks years in advance This study shows that specific ratios of circulating sphingolipids to steroids can predict the risk of future asthma exacerbations over five years with high discriminatory performance. By integrating metabolomics with longitudinal medical records, the research highlights lipid–hormone pathway imbalance as a key driver of asthma instability.

	Digital coaching boosts asthma control and quality of life While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the need for integrated approaches.

			New CHEST guidelines offer evidence-based biologic selection for severe asthma The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe asthma.

			DTU researchers discover gut bacteria link to reduced allergy and asthma risk Researchers from DTU have patented an invention that uses naturally produced substances from gut bacteria of the bifidobacteria type to reduce the risk of allergies and asthma.

	Novel method predicts asthma exacerbations with high degree of accuracy Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. The study is published in Nature Communications.

	Bedfont® Scientific Limited is pleased to support a major milestone to improve asthma care Bedfont® Scientific Limited, a medical device manufacturer based in Kent, with over 49 years’ experience in the breath analysis industry, was pleased to support its UK distributor, Intermedical UK, in supplying the 3,000th NObreath® Fractional exhaled Nitric Oxide (FeNO) device in the UK.

	Pandemic linked to lasting drops in diagnosis rates for major conditions There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026